Faraci F M, Heistad D D
Department of Internal Medicine, University of Iowa College of Medicine, Iowa City 52242.
Am J Physiol. 1993 Jan;264(1 Pt 2):H8-13. doi: 10.1152/ajpheart.1993.264.1.H8.
This study examined the hypothesis that activation of ATP-sensitive potassium channels produces vasodilation and contributes to dilator responses of the basilar artery to acetylcholine in vivo. Diameter of the basilar artery (baseline diam = 245 +/- 14 microns, means +/- SE) was measured through a cranial window in anesthetized rats. RP52891 (1 microM), a direct activator of ATP-sensitive potassium channels, increased the diameter of the basilar artery by 33 +/- 5%. Glibenclamide (1 microM), an inhibitor of ATP-sensitive potassium channels, did not alter baseline diameter but abolished responses of the basilar artery to RP52891. Topical application of acetylcholine (10 microM) for 3 min produced peak dilatation of 33 +/- 6% at 30 s and produced a sustained increase in diameter of 17 +/- 4%. Glibenclamide did not inhibit dilator responses of the basilar artery to acetylcholine. Nitro-L-arginine methyl ester (10 and 100 microM), which inhibits synthesis of endothelium-derived relaxing factor (EDRF), produced concentration-dependent inhibition of dilatation of the basilar artery in response to acetylcholine. Thus ATP-sensitive potassium channels are functional but do not appear to influence basal tone of the basilar artery. Dilator responses of the basilar artery to acetylcholine are dependent on formation of EDRF but not dependent on activity of glibenclamide-sensitive potassium channels.
本研究检验了这样一种假说,即ATP敏感性钾通道的激活可产生血管舒张,并在体内对基底动脉对乙酰胆碱的舒张反应起作用。通过在麻醉大鼠的颅骨视窗测量基底动脉直径(基线直径 = 245±14微米,均值±标准误)。ATP敏感性钾通道的直接激活剂RP52891(1微摩尔)使基底动脉直径增加了33±5%。ATP敏感性钾通道抑制剂格列本脲(1微摩尔)未改变基线直径,但消除了基底动脉对RP52891的反应。局部应用乙酰胆碱(10微摩尔)3分钟,在30秒时产生了33±6%的峰值舒张,并使直径持续增加17±4%。格列本脲未抑制基底动脉对乙酰胆碱的舒张反应。抑制内皮源性舒张因子(EDRF)合成的硝基-L-精氨酸甲酯(10和100微摩尔)对乙酰胆碱引起的基底动脉舒张产生浓度依赖性抑制。因此,ATP敏感性钾通道具有功能,但似乎不影响基底动脉的基础张力。基底动脉对乙酰胆碱的舒张反应依赖于EDRF的形成,但不依赖于格列本脲敏感钾通道的活性。